When evaluating the contribution of clinical and genetic predictors to RDS outcomes, clinical factors alone demonstrated high discrimination for disease occurrence, whereas the addition of IL-10 and NOS3 variants improved the discrimination of disease severity and mortality. Here, NOS3 is linked to newborn respiratory distress syndrome.